U.S. Residential REITs Stock News

NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative

Sotera Health (SHC) has put a full year of results on the table, with Q4 FY 2025 revenue of US$303.4 million and basic EPS of US$0.12, rounding out trailing 12 month revenue of about US$1.2 billion and EPS of US$0.27 that follows earnings growth of 75.8% over the past year. Over recent quarters the company has seen revenue move from US$254.5 million in Q1 FY 2025 to US$311.3 million in Q3 and US$303.4 million in Q4. Quarterly basic EPS has ranged from a loss of US$0.05 in Q1 to US$0.17 in Q3...
NYSE:EXPD
NYSE:EXPDLogistics

Expeditors International Of Washington (EXPD) Flat TTM Earnings Challenge Bullish Quality Narrative

Expeditors International of Washington (EXPD) just wrapped up FY 2025 with fourth quarter revenue of US$2.9 billion and basic EPS of US$1.50, alongside net income of US$200.7 million. Together, these results set the tone for how the full year will be judged. Over recent quarters, the company has seen revenue range from US$2.7 billion to US$3.0 billion, while quarterly EPS moved between roughly US$1.35 and US$1.69. This gives investors a clearer view of how the top and bottom lines have...
NasdaqCM:ESTA
NasdaqCM:ESTAMedical Equipment

Establishment Labs Holdings (ESTA) Q4 Loss NARROWS Sharply Reinforcing Bullish Profitability Narrative

Establishment Labs Holdings (NasdaqCM:ESTA) just wrapped FY 2025 with Q4 revenue of US$64.6 million and a basic EPS loss of US$0.09, alongside trailing twelve month revenue of US$211.1 million and a TTM basic EPS loss of US$1.72. The company has seen quarterly revenue move from US$40.2 million in Q3 2024 to US$64.6 million in Q4 2025, while quarterly basic EPS losses shifted from US$1.19 in Q4 2024 to US$0.09 in Q4 2025, setting up an earnings story where stronger top line figures are still...
NasdaqGS:COGT
NasdaqGS:COGTBiotechs

Cogent Biosciences Balances Bezuclastinib Phase 3 Progress With Dilution Risk

Cogent Biosciences (NasdaqGS:COGT) has advanced its lead therapy bezuclastinib into a Phase 3 trial for systemic mastocytosis. The company has also filed a significant shelf registration that could be used to raise capital in the future. These updates highlight progress in Cogent Biosciences' clinical pipeline alongside preparations for potential funding needs. Cogent Biosciences enters this news cycle with its shares at $39.18 and very large 1 year returns, reflecting strong recent...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

Upbound Group (UPBD) Margin Hit And One Off Loss Challenge Bullish Growth Narrative

Upbound Group (UPBD) has wrapped up FY 2025 with Q4 revenue of US$1.2 billion and basic EPS of US$0.35, while trailing twelve month figures show revenue of US$4.7 billion and EPS of US$1.30 against a current share price around US$21.62. Over the past six quarters, the company has seen revenue move from US$1.08 billion in Q4 2024 to US$1.20 billion in Q4 2025, with quarterly EPS ranging between US$0.23 and US$0.57 along the way. This gives investors a clear view of how the top line and per...
NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

Assessing ASML Holding (NasdaqGS:ASML) Valuation After A Strong Year Of Shareholder Returns

ASML Holding stock performance and business snapshot ASML Holding (NasdaqGS:ASML) has drawn investor attention recently, with the share price at $1,497.80 and total returns over the past year, 3 years, and 5 years all in positive territory. The company reports annual revenue of €32.67b and net income of €9.61b, with both revenue and earnings showing positive annual growth. ASML focuses on lithography, metrology, and inspection systems used in advanced semiconductor manufacturing. Its...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Tarsus Pharmaceuticals (TARS) Narrowing EPS Loss Backs Bullish Earnings Turnaround Narrative

Tarsus Pharmaceuticals (TARS) closed FY 2025 with fourth quarter revenue of US$151.7 million and a basic EPS loss of US$0.20, while net income excluding extra items came in at a loss of US$8.4 million. The company has seen quarterly revenue move from US$48.1 million and a basic EPS loss of US$0.61 in Q3 2024 to US$151.7 million and a loss of US$0.20 per share in Q4 2025. Trailing twelve month EPS stands at a loss of US$1.59 on revenue of US$451.4 million, outlining a picture where higher...
NasdaqGS:GLDD
NasdaqGS:GLDDConstruction

Great Lakes Dredge & Dock (GLDD) Net Margin Beats Narratives Of Future Compression

Great Lakes Dredge & Dock (GLDD) capped FY 2025 with Q4 revenue of US$256.5 million and basic EPS of US$0.19, rounding out a trailing twelve month picture that includes total revenue of US$888.3 million and EPS of US$1.10. Over the past few quarters, the company has seen revenue move from US$191.2 million in Q3 2024 to US$202.8 million in Q4 2024, then to US$242.9 million in Q1 2025 and US$195.2 million in Q3 2025, with quarterly EPS ranging from US$0.13 to US$0.50 over the same stretch. This...
NasdaqGS:PTLO
NasdaqGS:PTLOHospitality

Portillo’s (PTLO) Margin Compression To 2.6% Tests Bullish Profit Growth Narrative

Portillo's (PTLO) has wrapped up FY 2025 with fourth quarter revenue of US$185.7 million and basic EPS of US$0.08, alongside net income of US$6.1 million. This update gives investors an opportunity to reassess how the full year stacks up against its recent history. The company has seen quarterly revenue move from US$176.4 million in Q1 2025 to a range between US$181.4 million and US$188.5 million through the year, while EPS shifted between US$0.02 and US$0.13, giving a mixed read on profit...
NYSE:CYD
NYSE:CYDMachinery

China Yuchai International Earnings Growth Tests Bearish Narratives On Long Term Profitability

China Yuchai International (NYSE:CYD) has just posted its FY 2025 first half numbers, with revenue of C¥13.8b and basic EPS of C¥9.75, setting the tone for a year in which investors are closely tracking how earnings and sales are holding up. The company has seen revenue move from C¥10.3b in the first half of 2024 to C¥13.8b in the first half of 2025, while basic EPS went from C¥5.88 to C¥9.75 over the same period. With trailing 12 month EPS at C¥14.32 on revenue of C¥24.7b, the results put...
NYSE:EFX
NYSE:EFXProfessional Services

AI Credit Planner Launch Amid Rising Borrower Stress Could Be A Game Changer For Equifax (EFX)

In February 2026, Equifax launched Optimal Path, an AI-powered, interactive credit score planner that provides U.S. consumers with personalized, evolving 30-day action plans via the free myEquifax mobile app, integrating directly with their Equifax credit profiles. Alongside this product rollout, fresh Equifax credit data underscored widening financial stress for younger and highly leveraged borrowers, reinforcing the importance of real-time, personalized credit tools and positioning...
NYSE:OSG
NYSE:OSGInsurance

Octave Specialty Group NYSE OSG Combined Ratios Above 100% Reinforce Bearish Underwriting Narratives

Octave Specialty Group (OSG) just posted its FY 2025 numbers with Q4 total revenue of US$66.9 million and a basic EPS loss of US$0.66, while on a trailing twelve month basis revenue came in at US$251.2 million and EPS at a loss of US$2.09. The company has seen quarterly revenue move from US$65.2 million in Q4 FY 2024 to US$66.9 million in Q4 FY 2025, with basic EPS shifting from a loss of US$0.46 to a loss of US$0.66 over the same period. This sets the stage for investors to focus squarely on...
NasdaqGS:VNET
NasdaqGS:VNETIT

Does VNET Group’s (VNET) Finance Shake-Up Clarify Its Complex Capital Structure Or Deepen Uncertainty?

VNET Group, Inc. recently appointed Peter Zhihua Zhang as Senior Vice President of Operational Finance and principal accounting officer, giving him authority over financial operations and key SEC and Nasdaq filings while the company amended its US$250 million 2% convertible senior notes due 2027 with Blackstone-managed vehicles. The combination of a strengthened internal finance leadership role and changes to the convertible note terms has refocused attention on VNET’s governance, capital...
NYSE:JLL
NYSE:JLLReal Estate

Is It Time To Reassess JLL (JLL) After Recent Share Price Swings?

If you are wondering whether Jones Lang LaSalle is priced attractively today, a good starting point is understanding what the recent share moves are really telling you about value and risk. The stock last closed at US$310.97, after a 7 day return of 8.4%, a 30 day return showing a 12.2% decline, and returns of a 7.4% decline year to date and 17.1% over the past year, with longer term returns of 78.2% over 3 years and 74.5% over 5 years. Recent news around Jones Lang LaSalle has focused on...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

Electric Fracturing Deal Reframes Expand Energy Valuation And Future Returns

Expand Energy has partnered with Evolution Well Services to deploy 100% electric hydraulic fracturing technology in Northeast Appalachia. The initiative targets lower noise, a smaller equipment footprint, reduced surface disruption, and real time environmental monitoring. The move reflects a focus on operational efficiency and environmental performance that has not featured in recent company updates. For investors watching Expand Energy (NasdaqGS:EXE), this partnership adds a fresh...
NYSE:PRIM
NYSE:PRIMConstruction

Why Primoris Services (PRIM) Is Down 6.4% After Record 2025 Results And 2026 EPS Guidance

Primoris Services Corporation recently reported its fourth-quarter and full-year 2025 results, posting US$1,857.7 million in Q4 sales and US$7,574.9 million in full-year sales, alongside 2026 net income guidance of US$294.0 million to US$305.0 million and EPS guidance of US$5.35 to US$5.55. The company paired these results with a US$0.08 per-share cash dividend declaration and forward earnings guidance that frames how management views future profitability and capital returns. Now we’ll...
NYSE:CWEN.A
NYSE:CWEN.ARenewable Energy

Clearway Energy (CWEN.A) Q4 Loss Challenges Bullish Earnings Growth Narrative

Clearway Energy (CWEN.A) just closed out FY 2025 with Q4 revenue of US$310 million and a basic EPS loss of US$0.85, capping a trailing twelve month period that totaled US$1.4 billion of revenue and US$1.42 in basic EPS. The company has seen quarterly revenue move from US$256 million in Q4 2024 to US$310 million in Q4 2025. Over the same period, basic EPS shifted from US$0.03 to a loss of US$0.85, against a backdrop of trailing twelve month net income of US$169 million. For investors, that mix...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

Does Plains All American’s Cost-Saving Pure-Play Crude Pivot Reshape The Bull Case For PAA?

Earlier this month, Plains All American Pipeline, L.P. reported its fiscal Q4 2025 results, coming in below Wall Street earnings expectations while outlining progress on its business refocus. At the same time, management emphasized its plan to become a pure-play crude operator and pursue US$100 million in annual cost savings through 2027, with about half targeted for 2026, which could meaningfully reshape its cost structure and competitive positioning. Now we’ll examine how this renewed...
NYSE:NOG
NYSE:NOGOil and Gas

Is It Time To Reconsider Northern Oil and Gas (NOG) After Recent Share Price Weakness?

If you are wondering whether Northern Oil and Gas is offering fair value at its current share price, or if the market is missing something, this article will walk you through what the numbers are indicating. The stock most recently closed at US$27.30, with returns of 5.2% over the past week, 16.4% over the past month, 24.0% year to date and a 12.3% decline over the past year. This raises questions about how its current price lines up with its fundamentals. Recent news coverage around...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Assessing Align Technology (ALGN) Valuation After Recent Share Price Momentum

Align Technology (ALGN) has drawn investor attention after recent share price moves, with the stock up about 10% over the past month and 26% over the past 3 months, prompting closer scrutiny of its valuation. See our latest analysis for Align Technology. At a share price of US$185.53, Align’s short term momentum is positive, with a 1 month share price return of about 10% and a 3 month gain of roughly 26%. However, the 1 year total shareholder return is close to flat and longer term total...
NasdaqCM:LMB
NasdaqCM:LMBConstruction

Will Lower Import Tariffs on Materials Change Limbach Holdings' (LMB) Cost Advantage Narrative?

The U.S. Supreme Court recently overturned tariffs introduced under the Trump administration, a move expected to lower import costs for parts and materials used by U.S. manufacturers, including construction-related firms like Limbach Holdings. For Limbach, whose projects rely heavily on material and equipment inputs, reduced tariff-related costs could improve project economics and enhance the competitiveness of its building systems services. We’ll now examine how potentially lower input...
NasdaqGS:FTAI
NasdaqGS:FTAIAerospace & Defense

Is FTAI Aviation (FTAI) Quietly Recasting Its Engine Platform With Air France Jets And New Leaders?

Earlier this month, FTAI Aviation closed the acquisition of seven off-lease Airbus narrowbody aircraft from Air France, and also reshuffled its leadership team by appointing David Moreno as president and Stacy Kuperus as principal operating officer. These moves, alongside FTAI’s push to repurpose jet engines for powering data centers, underline how the company is broadening its engine-focused platform beyond traditional aviation. Next, we’ll examine how the Air France aircraft acquisition...
NYSE:VFC
NYSE:VFCLuxury

Trump Tariffs Test VF Corp Tariff Resilience And Turnaround Progress

The Trump administration announces a new 15% global tariff package. Tariffs apply to a wide range of imports, affecting VF Corp's international supply chain. VF Corp (NYSE:VFC), an apparel company with extensive global operations, faces new regulatory and cost uncertainties. VF Corp, the owner of multiple apparel and footwear brands, relies heavily on cross border sourcing and manufacturing. A 15% global tariff framework directly touches that setup, raising questions about input costs,...
NYSE:IRT
NYSE:IRTResidential REITs

A Look At Independence Realty Trust (IRT) Valuation As Mixed Returns Contrast With Rich P/E Multiple

Independence Realty Trust (IRT) has drawn attention after recent trading left the shares around $16.72, with mixed total returns over the past year and 3 years, prompting fresh investor interest in its multifamily REIT profile. See our latest analysis for Independence Realty Trust. Recent trading has been slightly positive, with a 1-day share price return of 1.64% and a 7-day share price return of 1.89%. However, the year to date share price return of 5.00% and 1-year total shareholder return...